Antiviral effects of CD4 derivatives.
Capon
D J
DJ
Genentech Incorporated, San Francisco, California.
Ward
R H
RH
D000888:Antibodies, Anti-Idiotypic / Q000276:immunology / Q000494:pharmacology; D015703:Antigens, CD / Q000494:pharmacology; D000998:Antiviral Agents / Q000494:pharmacology*; D015704:CD4 Antigens / Q000276:immunology / Q000378:metabolism; D016860:CD4 Immunoadhesins; D015496:CD4-Positive T-Lymphocytes / Q000382:microbiology; D005098:Exotoxins / Q000494:pharmacology; D006678:HIV / Q000502:physiology*; D015483:HIV Antibodies / Q000276:immunology; D015699:HIV Envelope Protein gp120 / Q000276:immunology / Q000378:metabolism; D006801:Humans; D007074:Immunoglobulin G / Q000494:pharmacology; D007130:Immunoglobulin Idiotypes / Q000276:immunology; D000922:Immunotoxins / Q000494:pharmacology; D010446:Peptide Fragments / Q000494:pharmacology; D011991:Receptors, Virus / Q000276:immunology / Q000378:metabolism; D011994:Recombinant Proteins / Q000494:pharmacology
D000888:Antibodies, Anti-Idiotypic; D015703:Antigens, CD; D000998:Antiviral Agents; D015704:CD4 Antigens; D016860:CD4 Immunoadhesins; C057689:CD4-Pseudomonas toxin; D005098:Exotoxins; D015483:HIV Antibodies; D015699:HIV Envelope Protein gp120; D007074:Immunoglobulin G; D007130:Immunoglobulin Idiotypes; D000922:Immunotoxins; D010446:Peptide Fragments; D011991:Receptors, Virus; D011994:Recombinant Proteins